Pharmacist comprehensive review of treatment compared with STOPP-START criteria to detect potentially inappropriate prescription in older complex patients
- PMID: 31156979
- PMCID: PMC6452406
- DOI: 10.1136/ejhpharm-2016-001054
Pharmacist comprehensive review of treatment compared with STOPP-START criteria to detect potentially inappropriate prescription in older complex patients
Abstract
Objectives: To compare potentially inappropriate prescribing (PIP) according to the clinical judgement of the pharmacist with PIP according to explicit STOPP-START criteria in institutionalised and hospitalised patients with multiple pathologies. To describe and compare the main pharmacological groups involved and determine the factors associated with the detection of PIP in these patients.
Method: A prospective multicentre observational study of institutionalised and hospitalised multipathology patients aged >65 years. A specialised pharmacist used his best clinical judgement to detect PIP based on a comprehensive review of the complete chronic treatment of patients, which is an essential activity in interdisciplinary care. STOPP-START criteria were used as an aid tool to detect PIP. The main variable was the number of PIP incidents detected.
Results: Detected PIP incidents were analysed in 338 patients. Clinical judgement detected more PIP incidents (35%) than did STOPP-START criteria. More PIP incidents unrelated to these criteria were detected in institutionalised patients than in hospitalised patients. Clinical judgement mainly detected PIP incidents related to incorrect doses and drug interactions (p<0.001); however, STOPP-START criteria mainly detected PIP incidents related to drug duplication and insufficiently treated diagnosis or symptoms (p=0.001 and p<0.001). In total, 93.8% of the PIP incidents were detected in polypharmacy patients (≥5 drugs). Institutionalised and high-level polypharmacy (≥10 drugs) patients were at the highest risk of PIP.
Conclusions: A large number of PIP incidents were detected in institutionalised and hospitalised patients with multiple pathologies. The inclusion of a pharmacist in the multidisciplinary team facilitated the detection of PIP incidents, particularly in the institutionalised population and patients treated with high-level polypharmacy which were not detected by explicit STOPP-START criteria.
Keywords: Elderly; Inappropriate prescription; Multipathology; Nursing homes; Pharmaceutical care; STOPP START Criteria.
Conflict of interest statement
Competing interests: None declared.
Similar articles
-
Potentially inappropriate prescribing in institutionalised older patients in Spain: the STOPP-START criteria compared with the Beers criteria.Pharm Pract (Granada). 2012 Apr;10(2):83-91. doi: 10.4321/s1886-36552012000200004. Epub 2012 Jun 30. Pharm Pract (Granada). 2012. PMID: 24155822 Free PMC article.
-
Ability to detect potentially inappropriate prescribing in older patients: comparative analysis between PIM-Check and STOPP/STARTv2.Eur J Clin Pharmacol. 2021 Nov;77(11):1747-1756. doi: 10.1007/s00228-021-03171-4. Epub 2021 Jun 30. Eur J Clin Pharmacol. 2021. PMID: 34191107 Free PMC article.
-
[Adequacy of the pharmacological prescription during the admission in a geriatric hospital. Clinical experiencie with STOPP/START criteria].J Healthc Qual Res. 2020 Mar-Apr;35(2):95-101. doi: 10.1016/j.jhqr.2020.02.001. Epub 2020 Mar 30. J Healthc Qual Res. 2020. PMID: 32241728 Spanish.
-
A Systematic Review of Studies of the STOPP/START 2015 and American Geriatric Society Beers 2015 Criteria in Patients ≥ 65 Years.Curr Aging Sci. 2019;12(2):121-154. doi: 10.2174/1874609812666190516093742. Curr Aging Sci. 2019. PMID: 31096900
-
STOPP/START criteria for potentially inappropriate medications/potential prescribing omissions in older people: uptake and clinical impact.Expert Rev Clin Pharmacol. 2023 Jul-Dec;16(12):1175-1185. doi: 10.1080/17512433.2023.2280219. Epub 2023 Dec 9. Expert Rev Clin Pharmacol. 2023. PMID: 37947757 Review.
Cited by
-
Multidisciplinary medication review during older patient hospitalization according to STOPP/START criteria reduces potentially inappropriate prescriptions: MoPIM cohort study.BMC Geriatr. 2024 Jul 8;24(1):584. doi: 10.1186/s12877-024-05185-w. BMC Geriatr. 2024. PMID: 38978009 Free PMC article.
-
Improving Pharmacists' Targeting of Patients for Medication Review and Deprescription.Pharmacy (Basel). 2018 Apr 16;6(2):32. doi: 10.3390/pharmacy6020032. Pharmacy (Basel). 2018. PMID: 29659552 Free PMC article.
-
Pharmacist comprehensive review of fall-risk-increasing drugs and polypharmacy in elderly Spanish community patients using RStudio®.Heliyon. 2023 Jun 13;9(6):e17079. doi: 10.1016/j.heliyon.2023.e17079. eCollection 2023 Jun. Heliyon. 2023. PMID: 37383189 Free PMC article.
References
-
- 2012. Plan Estratégico de la Sociedad Española de Farmacia Hospitalaria sobre Atención Farmacéutica al Paciente Crónico. SEFH. (20 October 2016). http://www.sefh.es/sefhpdfs/plan_estrategico_sefh_af_paciente_cronico201....
-
- 2012. Estrategia para el abordaje de la cronicidad en el Sistema Nacional de Salud. Ministerio de Sanidad, Servicios sociales e igualdad. (20 October 2016) http://www.msssi.gob.es/organizacion/sns/planCalidadSNS/pdf/ESTRATEGIA_A....
-
- Chronic diseases and health promotion. WHO. (20 October 2016). http://www.who.int/chp/en/
-
- Long Term Conditions. The Scottish Government. (20 October 2016). http://www.gov.scot/Topics/Health/Services/Long-Term-Conditions
-
- 2010. U.S. Department of Health and Human Services. Multiple Chronic Conditions. A Strategic Framework: Optimum Health and Quality of Life for Individuals with Multiple Chronic Conditions. Washington DC. December. (20 October 2016). http://www.hhs.gov/ash/initiatives/mcc/mcc_framework.pdf.
LinkOut - more resources
Full Text Sources